Phyllis Dan

Q: What is Phyllis Dan email address?

Email Phyllis Dan at phyllis@mileutis.com. This email is the most updated Phyllis Dan's email found in 2026.

Q: How to contact Phyllis Dan?

To contact Phyllis Dan send an email to phyllis@mileutis.com.

Senior Project Leader at CureTech | Jerusalem District, Israel

About Phyllis Dan

Phyllis Dan currently serves as a Senior Project Leader at CureTech, where she plays a pivotal role in advancing the development of bioanalytical methods critical for drug discovery and development. With a strong foundation in Good Manufacturing Practices (GMP), Phyllis expertly oversees the validation of complex methodologies, including cation exchange HPLC, size exclusion HPLC, and ELISA assays. Her meticulous approach ensures that all bioanalytical methods comply with stringent ICH and FDA guidelines, thereby facilitating the seamless progression of clinical trials.

In her role, Phyllis is not only responsible for the technical aspects of method development but also excels in scientific writing and editing. She crafts comprehensive Standard Operating Procedures (SOPs), study plans, and regulatory documentation that are essential for maintaining compliance and ensuring the integrity of research findings. Her proficiency in utilizing scientific literature databases and advanced scientific graphing programs allows her to stay at the forefront of industry advancements, ensuring that CureTech’s methodologies are both innovative and effective.

Phyllis also manages the qualification and validation of pharmacokinetic and immunogenicity assays performed by external contractors, demonstrating her strong project management skills and ability to collaborate effectively across teams. Her hands-on experience with quality control assays in a GMP environment further underscores her commitment to excellence in the lifesciences sector. With expertise in cell-based assays, protein expression, and cell biology, Phyllis Dan is a key asset to CureTech, driving impactful projects that contribute to the advancement of therapeutic solutions.

Phyllis Dan Work